Michael A. Nauck and David A. D‘Alessio

Michael A. Nauck, Bochum, Germany. Professor Michael Nauck is Head of Clinical Research, Diabetes, at the St. Josef Hospital, Ruhr-University Bochum, and has studied the physiology and pathophysiology as well as the therapeutic potential of the incretin hormones GIP and GLP-1 for 40 years. He was involved in proof-of-principle studies outlining the therapeutic potential of GLP-1 for type 2 diabetes.

Latest posts by Michael A. Nauck and David A. D‘Alessio (see all)